Evidence map›Paper›PMID 38078358›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2024

Design, synthesis, and biological evaluation of piperazine derivatives involved in the 5-HT

Hao Zhou, Mengjiao Li, Hui Liu, Zheng Liu, Xuekun Wang, Shiben Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hao ZhouSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Mengjiao LiSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Hui LiuCollege of Pharmacy, Yanbian University, Yanji, Jilin, China.
Zheng LiuSchool of Medicine, Foshan University, Foshan, Guangdong, China.
Xuekun WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Shiben WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Liaocheng University · CNFoshan University · CNYanbian University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, four series of piperazine derivatives were designed, synthesised and subjected to biological test, and compound

Indexed as

Brain-Derived Neurotrophic FactorSerotoninAnimalsBrainMiceMolecular Docking SimulationPiperazinesReceptor, Serotonin, 5-HT1ABrain-Derived Neurotrophic FactorPiperazinesReceptor, Serotonin, 5-HT1ASerotonin5-HT1ARantidepressantmolecular docking studiesPiperazinewestern blot

Identifiers

PMID38078358
PMCPMC11721615
OpenAlexW4389565429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.